An Advanced Mechanically Active Osteoarthritis‐on‐Chip Model to Test Injectable Therapeutic Formulations: The SYN321 Case Study
Source abstract
Abstract
Abstract Current treatments for osteoarthritis (OA) often fail to address the underlying pathophysiology and may have systemic side effects, particularly associated with long‐term use of non‐steroidal anti‐inflammatory drugs (NSAIDs). Thus, researchers are currently directing their efforts toward innovative polymer‐drug combinations, such as mixtures of hyaluronic acid viscoelastic hydrogels and NSAIDs like diclofenac, to ensure sustained release of the NSAID within the joint following intra‐articular injection. However, the progress of novel injectable therapies for OA is hindered by the absence of preclinical models that accurately represent the pathology of the disease. The uBeat® MultiCompress platform is here presented as a novel approach for studying anti‐OA injectable therapeutics on human mechanically‐damaged OA cartilage microtissues, in a physiologically relevant environment. This platform can accommodate injectable therapeutic formulations and is successfully tested with SYN321, a novel diclofenac‐sodium hyaluronate conjugate under development as a treatment for knee OA. Results indicate the platform's effectiveness in evaluating therapeutic potential, showing downregulation of inflammatory markers and reduction in matrix degradation in OA cartilage micro‐tissues treated with SYN321. The uBeat® MultiCompress platform thus represents a valuable tool for OA research, offering a bridge between traditional in vitro studies and potential clinical applications, with implications for future drug discovery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Tendon Structure and Treatment · Total Knee Arthroplasty Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Electronics Information and Bioengineering Politecnico di Milano Via Ponzio 34/5 Milan 20133 Italy
BiomimX Srl Viale Decumano 41 MIND – Milano Innovation District Milan 20157 Italy
Recipharm OT Chemistry AB Virdings allé 18 Uppsala 754 50 Sweden
UB‐consulting AB Trädgårdsgatan 7A Uppsala 753 09 Sweden
Synartro AB Dalgatan 16A Uppsala 752 18 Sweden
Funding
Fondazione Cariplo
References (72)
Show source-provided references
1. 10.1038/nrdp.2016.7210.1038/nrdp.2016.72 ↗
2. 10.1007/s40273-016-0424-x10.1007/s40273-016-0424-x ↗
3. 10.1002/art.4208910.1002/art.42089 ↗
4. 10.1016/j.bbapap.2011.06.02010.1016/j.bbapap.2011.06.020 ↗
5. 10.1111/nyas.1393010.1111/nyas.13930 ↗
6. 10.1002/art.3445310.1002/art.34453 ↗
7. 10.3389/fphar.2022.94587610.3389/fphar.2022.945876 ↗
8. 10.1007/s40122-021-00260-110.1007/s40122-021-00260-1 ↗
9. 10.1021/acsnano.2c0639310.1021/acsnano.2c06393 ↗
10. 10.1097/MD.000000000003035410.1097/MD.0000000000030354 ↗
11. 10.1007/s40266-019-00660-110.1007/s40266-019-00660-1 ↗
12. 10.1016/j.ijpharm.2020.11951910.1016/j.ijpharm.2020.119519 ↗
13. 10.1111/jvp.1303310.1111/jvp.13033 ↗
14. 10.1016/j.drudis.2018.05.02310.1016/j.drudis.2018.05.023 ↗
15. 10.1002/art.4172510.1002/art.41725 ↗
16. Chavda S. · Cureus · 2022 · 14 · 4
17. 10.3390/jcm1201000510.3390/jcm12010005 ↗
18. Pitcher T. · J. Vis. Exp. · 2016 · 111
19. 10.1186/s12891-022-05937-y10.1186/s12891-022-05937-y ↗
20. 10.1186/s13018-016-0346-510.1186/s13018-016-0346-5 ↗
21. 10.1186/s13075-015-0747-610.1186/s13075-015-0747-6 ↗
22. 10.1177/2041731423117258410.1177/20417314231172584 ↗
23. Guilak F. · Clin. Rheumatol. · 2011 · 25 · 815
24. 10.1016/j.joca.2022.03.01210.1016/j.joca.2022.03.012 ↗
25. 10.1038/s41584-021-00736-610.1038/s41584-021-00736-6 ↗
26. 10.1039/C8LC00320C10.1039/C8LC00320C ↗
27. C. A.Paggi B.Venzac M.Karperien J. C. H.Leijten S. L. e.Gac 2020 7 315.10.1016/j.snb.2020.127917 ↗
28. 10.1038/s41551-019-0406-310.1038/s41551-019-0406-3 ↗
29. 10.1177/194760351668458810.1177/1947603516684588 ↗
30. 10.1039/C5LC01356A10.1039/C5LC01356A ↗
31. 10.1186/s12891-015-0775-z10.1186/s12891-015-0775-z ↗
32. 10.1136/annrheumdis-2013-20476310.1136/annrheumdis-2013-204763 ↗
33. 10.3389/fphys.2022.101140710.3389/fphys.2022.1011407 ↗
34. 10.1111/jcmm.1520410.1111/jcmm.15204 ↗
35. 10.1007/s11926-013-0375-610.1007/s11926-013-0375-6 ↗
36. 10.1002/jor.2367010.1002/jor.23670 ↗
37. 10.1016/j.cis.2023.10303010.1016/j.cis.2023.103030 ↗
38. 10.1186/s40634-014-0008-710.1186/s40634-014-0008-7 ↗
39. 10.1186/s40824-018-0118-x10.1186/s40824-018-0118-x ↗
40. 10.1002/art.1095010.1002/art.10950 ↗
41. 10.1038/s41413-022-00226-910.1038/s41413-022-00226-9 ↗
42. 10.1152/ajpcell.00544.202210.1152/ajpcell.00544.2022 ↗
43. 10.3389/fcell.2022.88522410.3389/fcell.2022.885224 ↗
44. 10.1039/D1BM00413A10.1039/D1BM00413A ↗
45. 10.1126/science.119327010.1126/science.1193270 ↗
46. 10.1016/j.carbpol.2012.06.07110.1016/j.carbpol.2012.06.071 ↗
47. 10.1679/aohc.61.12510.1679/aohc.61.125 ↗
48. 10.1093/rheumatology/keaa24810.1093/rheumatology/keaa248 ↗
49. 10.1002/jor.2121610.1002/jor.21216 ↗
50. 10.1186/ar388710.1186/ar3887 ↗
51. Migliore A. · Clinical Cases in Mineral and Bone Metabolism · 2015 · 12 · 31
52. 10.1186/s12891-017-1743-610.1186/s12891-017-1743-6 ↗
53. 10.1016/j.tips.2021.12.00410.1016/j.tips.2021.12.004 ↗
54. 10.1186/ar417410.1186/ar4174 ↗
55. 10.1186/s12891-018-2077-810.1186/s12891-018-2077-8 ↗
56. 10.2478/intox-2013-001910.2478/intox-2013-0019 ↗
57. 10.1055/s-2008-103978610.1055/s-2008-1039786 ↗
58. Geborek P. · J Rheumatol · 1988 · 15 · 91
59. 10.1080/10717544.2022.204813010.1080/10717544.2022.2048130 ↗
60. 10.3390/ijms2204174210.3390/ijms22041742 ↗
61. E.Curtis N.Fuggle S.Shaw L.Spooner G.Ntani C.Parsons N.Corp G.Honvo J.Baird S.Maggi E.Dennison O.Bruyère J.Reginster C.Cooper 2019 36 25‐44.10.1007/s40266-019-00664-x ↗
62. 10.3390/cells1124403410.3390/cells11244034 ↗
63. 10.1016/j.joca.2019.12.00710.1016/j.joca.2019.12.007 ↗
64. 10.1016/j.bbiosy.2024.10009010.1016/j.bbiosy.2024.100090 ↗
65. 10.1038/s41584-019-0364-x10.1038/s41584-019-0364-x ↗
66. 10.1186/s13075-022-02804-y10.1186/s13075-022-02804-y ↗
67. 10.1016/j.coche.2016.01.01110.1016/j.coche.2016.01.011 ↗
68. 10.1016/j.devcel.2021.05.01110.1016/j.devcel.2021.05.011 ↗
69. 10.3389/fcell.2020.0033410.3389/fcell.2020.00334 ↗
70. 10.3390/cells812160710.3390/cells8121607 ↗
71. Carver W. · Biomed Res. Int. · 2013 · 1
72. 10.1007/978-1-0716-1693-2_110.1007/978-1-0716-1693-2_1 ↗